23 May 2013
Keywords: pfizer, suspends, sales, bextra, uk, drug, giant
Article | 25 April 2005
US drug giant Pfizer says that it has agreed to voluntarily suspend sales and marketing of its COX-2 inhibitor Bextra ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 April 2005
11 April 2005
© 2013 thepharmaletter.com